Breast Cancer Rates Higher in Urban vs. Rural Areas
Medically reviewed by Drugs.com.
By Ernie Mundell and Carole Tanzer Miller HealthDay Reporters
WEDNESDAY, Nov. 22, 2023 -- Environmental contaminants may be driving higher rates of breast cancer in urban areas compared to rural locales, a new North Carolina study finds.
“Our analyses indicate significant associations between environmental quality and breast cancer incidence," said lead author Larisa Gearhart-Serna, who led the research as a Ph.D. candidate at the Duke Cancer Institute in Durham, N.C.
The findings, published Nov. 20 in Scientific Reports, were based on data from the Environmental Quality Index (EQI) for North Carolina residents.
The EQI is "a county-by-county assessment of air, water, land, built environment, as well as the sociodemographic environment,” study senior author Gayathri Devi explained in a Duke news release. She's a professor of surgery and pathology and director of the Duke Consortium for Inflammatory Breast Cancer at the institute.
Devi and Gearhart-Serna compared EQI data against information on breast cancer case incidence (and cancer stage upon diagnosis) across North Carolina.
The team believe the state is a good model for disparities in breast cancer risk, with 10 million people spread across 100 rural and urban counties.
Some counties have better "environmental quality" than others, and the Duke team found that folks living in counties with poor environmental quality had about 11 more cases of breast cancer per 100,000 residents, compared to counties with good environmental quality.
That was especially true for cases of early (localized) breast cancer, they noted.
Urban counties with poor environmental quality were especially hard-hit by excess breast cancer cases. In some counties (both urban and rural), land contaminants such as pesticides, toxic chemicals from industry or agriculture appeared to play a role in cancer rates, the researchers said.
In North Carolina, black women appeared especially vulnerable. Counties with high percentages of black female residents had higher rates of late-stage breast cancer diagnoses, the study found. It's possible that lower rates of screening mammography might play a role in that disparity, the team said.
Gearhart-Serna said in the news release that the findings are crucial to "identifying a critical need to assess cumulative environmental exposures in the context of cancer stage. This has the potential to develop measures to reduce disease incidence in vulnerable communities.”
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-11-22 20:52
Read more
- Female Pediatricians Earn About 93 Percent of Male Pediatricians
- Nipocalimab is the First and Only Investigational Therapy Granted U.S. FDA Breakthrough Therapy Designation for the Treatment of Adults Living with Moderate-to-Severe Sjögren’s Disease
- Doctors Report First U.S. Cases of Sexually Transmitted Ringworm Rash
- McDonald's Quarter Pounder Beef Patties Not Source of E. Coli Contamination
- Merck’s Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus (RSV) Preventative Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and Hospitalization in Healthy Preterm and Full-term Infants
- ASN: Atrasentan Significantly and Clinically Meaningfully Cuts Proteinuria
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions